224 related articles for article (PubMed ID: 25406123)
1. European ombudsman questions European Medicines Agency over AbbVie redactions.
Watson R
BMJ; 2014 Nov; 349():g6904. PubMed ID: 25406123
[No Abstract] [Full Text] [Related]
2. European Medicines Agency pledges to publish clinical reports.
Watson R
BMJ; 2014 Oct; 349():g6086. PubMed ID: 25294699
[No Abstract] [Full Text] [Related]
3. AbbVie considers harms to be commercially confidential information: sign a petition.
Gøtzsche PC
BMJ; 2013 Dec; 347():f7569. PubMed ID: 24366821
[No Abstract] [Full Text] [Related]
4. The European Medicines Agency's plans for sharing data from clinical trials.
Groves T; Godlee F
BMJ; 2013 May; 346():f2961. PubMed ID: 23657192
[No Abstract] [Full Text] [Related]
5. Drug company drops case after EMA agrees to redactions in some documents to be published.
Dyer C
BMJ; 2014 Apr; 348():g2632. PubMed ID: 24709373
[No Abstract] [Full Text] [Related]
6. How can we regulate medicines better?
Garattini S; Bertele' V
BMJ; 2007 Oct; 335(7624):803-5. PubMed ID: 17947785
[TBL] [Abstract][Full Text] [Related]
7. EU directive on clinical trials penalizes small sponsors.
Meldolesi A
Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186
[No Abstract] [Full Text] [Related]
8. The European Medicines Agency: an overview of its mission, responsibilities, and recent initiatives in cancer drug regulation.
Pignatti F; Gravanis I; Herold R; Vamvakas S; Jonsson B; Marty M
Clin Cancer Res; 2011 Aug; 17(16):5220-5. PubMed ID: 21844037
[TBL] [Abstract][Full Text] [Related]
9. Drug regulation 2056.
Bezold C; Peck J
Food Drug Law J; 2005; 60(2):127-36. PubMed ID: 16097091
[No Abstract] [Full Text] [Related]
10. Lessons from Eprex for biogeneric firms.
Louët S
Nat Biotechnol; 2003 Sep; 21(9):956-7. PubMed ID: 12949539
[No Abstract] [Full Text] [Related]
11. Informed by the European Union experience: what the United States can anticipate and learn from the European Union's regulatory approach to biosimilars.
Gitter DM
Seton Hall Law Rev; 2011; 41(2):559-92. PubMed ID: 21739759
[No Abstract] [Full Text] [Related]
12. The European Medicines Agency: a public health European agency?
Mahalatchimy A; Rial-Sebbag E; De Grove-Valdeyron N; Tournay V; Cambon-Thomsen A; Duguet AM; Taboulet F
Med Law; 2012 Mar; 31(1):25-42. PubMed ID: 22908736
[TBL] [Abstract][Full Text] [Related]
13. European Ombudsman ramps up action against European Medicines Agency over data transparency plans.
Torjesen I
BMJ; 2014 Jun; 348():g3733. PubMed ID: 24904032
[No Abstract] [Full Text] [Related]
14. Medicines agencies too often under the influence of drug companies.
Prescrire Int; 2011 Apr; 20(115):108. PubMed ID: 21648219
[No Abstract] [Full Text] [Related]
15. Provision of information on regulatory authorities' websites.
Vitry A; Lexchin J; Sasich L; Dupin-Spriet T; Reed T; Bertele V; Garattini S; Toop L; Hurley E
Intern Med J; 2008 Jul; 38(7):559-67. PubMed ID: 18336542
[TBL] [Abstract][Full Text] [Related]
16. Progressive licensing needs progressive open debate.
Hébert PC; Stanbrook M; Sibbald B; Flegel K; MacDonald N; Attaran A
CMAJ; 2007 Jun; 176(13):1801, 1803. PubMed ID: 17576971
[No Abstract] [Full Text] [Related]
17. Best-kept secrets.
Nat Biotechnol; 2014 Jun; 32(6):499. PubMed ID: 24911473
[No Abstract] [Full Text] [Related]
18. FDA tightens its grip on drug regulation.
Coombes R
BMJ; 2007 Feb; 334(7588):290-1. PubMed ID: 17289729
[TBL] [Abstract][Full Text] [Related]
19. Out in the open.
Nat Biotechnol; 2005 Feb; 23(2):153. PubMed ID: 15696130
[No Abstract] [Full Text] [Related]
20. Glaxo agrees to post results of drug trials on web site.
Harris G
N Y Times Web; 2004 Aug; ():C4. PubMed ID: 15540364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
